Matches in Wikidata for { <http://www.wikidata.org/entity/Q46813064> ?p ?o ?g. }
- Q46813064 description "2007 nî lūn-bûn" @default.
- Q46813064 description "2007年の論文" @default.
- Q46813064 description "2007年学术文章" @default.
- Q46813064 description "2007年学术文章" @default.
- Q46813064 description "2007年学术文章" @default.
- Q46813064 description "2007年学术文章" @default.
- Q46813064 description "2007年学术文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007年學術文章" @default.
- Q46813064 description "2007년 논문" @default.
- Q46813064 description "article científic" @default.
- Q46813064 description "article scientific" @default.
- Q46813064 description "article scientifique (publié 2007)" @default.
- Q46813064 description "articol științific" @default.
- Q46813064 description "articolo scientifico" @default.
- Q46813064 description "artigo científico (publicado na 2007)" @default.
- Q46813064 description "artigo científico (publicado na 2007)" @default.
- Q46813064 description "artigo científico" @default.
- Q46813064 description "artikull shkencor" @default.
- Q46813064 description "artikulong pang-agham" @default.
- Q46813064 description "artykuł naukowy" @default.
- Q46813064 description "artículo científico publicado en 2007" @default.
- Q46813064 description "artículu científicu" @default.
- Q46813064 description "bilimsel makale" @default.
- Q46813064 description "bài báo khoa học" @default.
- Q46813064 description "mokslinis straipsnis" @default.
- Q46813064 description "naučni članak" @default.
- Q46813064 description "scienca artikolo" @default.
- Q46813064 description "scientific article" @default.
- Q46813064 description "teaduslik artikkel" @default.
- Q46813064 description "tieteellinen artikkeli" @default.
- Q46813064 description "tudományos cikk" @default.
- Q46813064 description "vedecký článok" @default.
- Q46813064 description "vetenskaplig artikel" @default.
- Q46813064 description "videnskabelig artikel (udgivet 2007)" @default.
- Q46813064 description "vitenskapelig artikkel" @default.
- Q46813064 description "vitskapeleg artikkel" @default.
- Q46813064 description "vědecký článek" @default.
- Q46813064 description "wetenschappelijk artikel" @default.
- Q46813064 description "wissenschaftlicher Artikel" @default.
- Q46813064 description "επιστημονικό άρθρο" @default.
- Q46813064 description "мақолаи илмӣ" @default.
- Q46813064 description "мақолаи илмӣ" @default.
- Q46813064 description "наукова стаття, опублікована в серпні 2007" @default.
- Q46813064 description "научна статия" @default.
- Q46813064 description "научная статья" @default.
- Q46813064 description "научни чланак" @default.
- Q46813064 description "научни чланак" @default.
- Q46813064 description "գիտական հոդված" @default.
- Q46813064 description "מאמר מדעי" @default.
- Q46813064 description "سائنسی مضمون" @default.
- Q46813064 description "مقالة علمية" @default.
- Q46813064 description "مقالهٔ علمی" @default.
- Q46813064 description "২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46813064 description "บทความทางวิทยาศาสตร์" @default.
- Q46813064 description "სამეცნიერო სტატია" @default.
- Q46813064 name "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 name "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 type Item @default.
- Q46813064 label "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 label "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 prefLabel "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 prefLabel "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.
- Q46813064 P1433 Q46813064-F2D850F4-01FC-4504-981B-9D31EAF191BA @default.
- Q46813064 P1476 Q46813064-DD23871F-D96F-45F2-93C7-1CD8550590D0 @default.
- Q46813064 P2093 Q46813064-050000CD-317F-4BC9-9A75-C4FB089A3985 @default.
- Q46813064 P2093 Q46813064-B6628D63-38CA-44B5-9D89-CDC798AB4CA9 @default.
- Q46813064 P2093 Q46813064-D8DBFE19-2581-49E2-AB0D-6C294BAAF360 @default.
- Q46813064 P2093 Q46813064-F3053BB7-C54F-4871-B5B3-6D65635801EB @default.
- Q46813064 P2860 Q46813064-00788EF3-FA79-4B6C-92FC-807FF4EFF608 @default.
- Q46813064 P2860 Q46813064-08DC482E-96D4-4820-B78D-CEDBF5FA1773 @default.
- Q46813064 P2860 Q46813064-0CC6A392-BD1D-4DC6-BA57-05AC0C13F826 @default.
- Q46813064 P2860 Q46813064-398A7A2D-8CF4-4886-9C22-F7E92A4937CA @default.
- Q46813064 P2860 Q46813064-415D3B4E-376F-4F49-808A-439ACF8EEBEA @default.
- Q46813064 P2860 Q46813064-476C304C-41EA-4EC3-88A4-D6C45A9FC787 @default.
- Q46813064 P2860 Q46813064-564A7BDC-1740-4785-9116-440D6D343B6E @default.
- Q46813064 P2860 Q46813064-6F86F783-E8E9-4DFD-88C3-955F482AFC76 @default.
- Q46813064 P2860 Q46813064-9F404C9A-A294-4C93-8EB2-B71CE460A26E @default.
- Q46813064 P2860 Q46813064-B8197374-0E1B-4338-A920-2780E3D32286 @default.
- Q46813064 P2860 Q46813064-CB38D08C-55EE-452A-9E84-1A1290267D1A @default.
- Q46813064 P2860 Q46813064-F5130EFA-D1BE-442E-AC60-49A3CE10EBBF @default.
- Q46813064 P2888 Q46813064-7BCB49C6-725C-47D9-B7C4-96C653235330 @default.
- Q46813064 P304 Q46813064-DF4C98A6-24FF-465B-A92F-9D9E63B6F3E3 @default.
- Q46813064 P31 Q46813064-64407715-4CF5-492A-9400-6D0F6CC72199 @default.
- Q46813064 P356 Q46813064-1E818C9C-FF7D-4C31-AA7E-EFF9D115759D @default.
- Q46813064 P433 Q46813064-097FE0D3-6CA7-47E4-8F92-FB5B5CD82B49 @default.
- Q46813064 P478 Q46813064-4699FF04-8FEA-4CD1-BE68-368A1838850C @default.
- Q46813064 P577 Q46813064-F9FB9794-209D-4A86-8351-8F86991320FB @default.
- Q46813064 P698 Q46813064-BA37EB2E-56EF-40C3-BC4F-698D99FFF84A @default.
- Q46813064 P921 Q46813064-2F7CDDC6-3C1B-49AA-A6A7-871550E2E35C @default.
- Q46813064 P921 Q46813064-3A6719F5-1A2E-4C67-8307-83F3B12DD0A6 @default.
- Q46813064 P921 Q46813064-7D9B7AD6-63B7-4688-B458-AC098C4F0186 @default.
- Q46813064 P356 S12032-007-0053-5 @default.
- Q46813064 P698 18188725 @default.
- Q46813064 P1433 Q2152666 @default.
- Q46813064 P1476 "Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor" @default.